DSP-2230 is a selective Nav1.7/Nav1.8 blocker.

Levobupivacaine HCl [also known as (S)-(-)-Bupivacaine; Chirocaine, Novabupi], the hydrochloride salt of Levobupivacaine which is the pure S(-)-enantiomer of bupivacaine, is a reversible neuronal sodium channel inhibitor.

Benzamil is an Amiloride analogue acting as a Na+/Ca2+ exchanger (NCX) inhibitor (IC50~100 nM) with the potential to treat cystic fibrosis.

GS967 (also known as GS-458967) is a novel, potent, and selective sodium channel inhibitor exhibiting potent antiarrhythmic effects in various in vitro and in vivo models.

CRMP2-Ubc9-NaV1.7 inhibitor 194 can prevent the SUMOylation of the NaV1.7-interacting protein CRMP2 and reduce NaV1.7 surface expression as well as current density.

Nav1.7 inhibitor is a novel and potent Voltage-gated sodium channel inhibitor with potential usefulness in pain therapy and as a local anaesthetic.

DPI-201-106 [(±)-SDZ-201 106] is a novel and potent inhibitor of the TTX-resistant h1 Na channel which is cardioselective.

PF-01247324 is a novel, potent, selective and orally bioavailable Nav1.8 channel blocker with an IC50 of 196 nM for recombinant human Nav1.8 channel.

Oxcarbazepine (also known as GP47680; GP-47680, Timox, Trileptal), a sodium channel protein inhibitor, is an anticonvulsant drug used in the treatment of epilepsy.

Cariporide is a selective Na+/H+ exchanger isoform 1 (NHE1) inhibitor.